CART-TM4SF1
/ Shanghai Ultra-T Immune Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 06, 2023
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System
(clinicaltrials.gov)
- P=N/A | N=24 | Not yet recruiting | Sponsor: Changhai Hospital
New trial • Gastrointestinal Cancer • Oncology • IFIT3 • TM4SF1
1 to 1
Of
1
Go to page
1